Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
John J. NicolsPresident & CEO973,2882.46%2015-02-10
Mr. Douglas T. SheehySVP, General Counsel & Sec.239,1720.6%2015-02-10
Dr. Patrick Y. Yang, PhDN/A229,5150.58%2014-11-18
James LalondeSVP, R&D168,9380.43%2015-02-10
Bernard KelleyDirector160,9490.41%2014-06-11
Thomas R. BaruchDirector138,4510.35%2014-06-11
Mr. Byron L. DorganN/A135,9510.34%2014-06-11
Mr. Dennis P. WolfN/A135,9510.34%2014-06-11
Mr. David D. O'TooleSVP & CFO110,6870.28%2013-09-04
Dr. David L. AntonSVP, BioIndustrials93,7770.24%2013-02-10

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
Yang Patrick YDirector2014-11-18Buy20,000229,515$2.354760.85Link
Yang Patrick YDirector2014-11-17Buy20,000209,515$2.3446.861.54Link
CMEA VENTURES LIFE SCIENCES 20Director, 10% Owner2014-11-10Sell2,921,2250$2.376923.359.49Link
Yang Patrick YDirector2014-08-12Buy60,000189,515$2.22133.270.27Link
NICOLS JOHN JPresident & CEO
(Click for the stocks that their CEOs have bought)
2013-03-08Buy27,000911,000$2.4265.356.2Link
NICOLS JOHN JPresident & CEO2013-03-07Buy54,000884,000$2.22119.970.27Link
O'Toole David DSVP & CFO2013-03-04Buy10,000115,384$2.0220.287.13Link
O'Toole David DSVP & CFO2012-11-12Buy5,00060,000$2.21171.82Link
O'Toole David DSVP & CFO2012-09-14Buy5,00055,000$2.7813.935.97Link
Sheehy Douglas T.SVP, General Counsel & Sec.2012-09-14Sell3,80069,200$2.7610.536.96Link
Anton David L.SVP, BioIndustrials2012-09-14Sell3,80070,200$2.7610.536.96Link
SHAW ALANPresident and CEO2011-12-16Sell53,846277,000$5.28284.3-28.41Link
SHAW ALANPresident and CEO2011-12-14Sell37,820330,846$5.27199.3-28.27Link
SHAW ALANPresident and CEO2011-07-07Sell15,000368,666$10.13152-62.69Link
SHAW ALANPresident and CEO2011-06-02Sell15,000368,666$10.39155.9-63.62Link
Lawson Robert JSVP and CFO2011-05-11Buy2,00044,000$9.519-60.21Link
SHAW ALANPresident and CEO2011-05-02Sell15,000268,666$10.44156.6-63.79Link
SHAW ALANPresident and CEO2011-04-01Sell15,000268,666$12.07181.1-68.68Link
SHAW ALANPresident and CEO2011-03-01Sell15,000218,666$10.65159.8-64.51Link
SHAW ALANPresident and CEO2011-02-11Sell15,000218,666$10.46156.9-63.86Link
BARUCH THOMAS RDirector2010-08-27Buy2,5002,742,658$7.5518.9-49.93Link
Pasternack Bruce ADirector2010-08-24Buy10,00010,000$7.7877.8-51.41Link
SHAW ALANPresident and CEO2010-08-10Buy2,00096,132$816-52.75Link
Sheehy Douglas T.SVP, Gen Counsel and Sec.2010-08-10Buy1,0001,000$7.998-52.69Link
Sarret Joseph J.CBO, President Pharmaceuticals2010-08-10Buy2,00015,333$7.9916-52.69Link
Lawson Robert JSVP and CFO2010-08-10Buy2,0002,000$816-52.75Link
Anton David L.SVP, Research and Development2010-08-10Buy2,0002,000$7.9916-52.69Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK